ArticleThe Journal of clinical investigation2022

KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer.

Yuming Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.